ACUTE MYELOID LEUKEMIA WITH BCR-ABL1

Clinical trials for ACUTE MYELOID LEUKEMIA WITH BCR-ABL1 explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOID LEUKEMIA WITH BCR-ABL1 trials appear

Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA WITH BCR-ABL1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to control Tough-to-Treat blood cancer

Disease control Ongoing

This study is testing a multi-step treatment plan for adults with a specific, aggressive form of leukemia (ALL) that has come back or hasn't responded to prior therapy. The plan combines lower-intensity chemotherapy with two targeted drugs, ponatinib and blinatumomab, to attack t…

Matched conditions: ACUTE MYELOID LEUKEMIA WITH BCR-ABL1

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

ACUTE MYELOID LEUKEMIA WITH BCR-ABL1

Get alerted when new ACUTE MYELOID LEUKEMIA WITH BCR-ABL1 trials appear

New drug combo aims to control Tough-to-Treat blood cancer